Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;56(9):4973-5.
doi: 10.1128/AAC.06402-11. Epub 2012 Jul 2.

Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?

Affiliations

Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?

Thu Thuy Nguyen et al. Antimicrob Agents Chemother. 2012 Sep.

Abstract

We assessed in a piglet model the relationship between fecal ciprofloxacin concentrations and ciprofloxacin-resistant Enterobacteriaceae counts. Twenty-nine piglets were orally treated with placebo or with 1.5 or 15 mg ciprofloxacin/kg of body weight/day from day 1 (D1) to D5. Areas under the curve (AUC) of concentrations increased sharply with dose and correlated positively with AUC of resistant bacteria log counts between D1 and D9. Removing residual colonic quinolones could help to control the emergence of resistance in fecal flora.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Mean (and 95% confidence intervals) of ciprofloxacin concentrations (A) and of log counts of ciprofloxacin-resistant Enterobacteriaceae (B) as well as of percentages of Enterobacteriaceae resistant to ciprofloxacin (C) in fecal samples from piglets treated with placebo (n = 9) and 1.5 mg/kg/day (n = 10) and 15 mg/kg/day (n = 10) of oral ciprofloxacin from day 1 to day 9.
Fig 2
Fig 2
Relationship between individual AUC of fecal concentrations of ciprofloxacin (AUC_CIP) versus AUC of log counts of fecal ciprofloxacin-resistant Enterobacteriaceae (AUC_RES) (A) and versus AUC of percentages of ciprofloxacin-resistant Enterobacteriaceae (AUC_%RES) (B) for 29 piglets in 3 treatment groups. Each symbol represents the AUC_CIP and AUC_RES or AUC_%RES values for one piglet. The black curve among the symbols is the mean curve predicted by the Emax model.

Similar articles

Cited by

References

    1. Baquero F, Coque TM, de la Cruz F. 2011. Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob. Agents Chemother. 55:3649–3660 - PMC - PubMed
    1. Donskey C. 2004. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39:219–226 - PubMed
    1. Fantin B, et al. 2009. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J. Infect. Dis. 200:390–398 - PMC - PubMed
    1. Khoder L, Tsapis N, Domergue-Dupont V, Gueutin C, Fattal E. 2010. Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. Eur. J. Pharm. Sci. 41:281–288 - PubMed
    1. Kitsis MD. 2009. Measurement of antibiotics in human body fluids. In Courvalin P, Leclercq R, Rice L. (ed), Antibiogram. ESKA and ASM Press, Washington, DC

Publication types